Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • November 2006 (Revised July 2008)
  • Case
  • HBS Case Collection

Eli Lilly: Developing Cymbalta

By: Elie Ofek and Ron Laufer
  • Format:Print
  • | Pages:28
ShareBar

Abstract

Anticipating the expiration of its Prozac patent, Eli Lilly has to make tough decisions regarding the development of its next-generation antidepressant drug. In particular, the company needs to decide whether to first establish that once-a-day dosing for Cymbalta (Duloxetine) is effective in treating major depressive disorder and only after launch get FDA approval for treating painful physical symptoms, or to first establish efficacy in treating pain and later get FDA approval for once-a-day dosing. The decision needs to take into account how Cymbalta can be differentiated in the marketplace vis-à-vis other antidepressants and the marketing challenges to getting adoption that the new drug will face. Lilly's new antidepressant team making this decision has several market research inputs on physicians and patients at its disposal.

Keywords

Decision Choices and Conditions; Marketing Strategy; Product Launch; Product Development; Research and Development; Pharmaceutical Industry

Citation

Ofek, Elie, and Ron Laufer. "Eli Lilly: Developing Cymbalta." Harvard Business School Case 507-044, November 2006. (Revised July 2008.)
  • Educators
  • Purchase

About The Author

Elie Ofek

Marketing
→More Publications

More from the Authors

    • May 2022
    • Faculty Research

    Thinking Outside the Wine Box (C): Mekanism and the Franz for Life Campaign

    By: Tomomichi Amano, Elie Ofek, Mengjie Cheng and Amy Klopfenstein
    • May 2022
    • Faculty Research

    Thinking Outside the Wine Box (B): Mekanism and the Franz for Life Campaign

    By: Tomomichi Amano, Elie Ofek, Mengjie Cheng and Amy Klopfenstein
    • May 2022
    • Faculty Research

    Thinking Outside the Wine Box (A): Mekanism and the Franz for Life Campaign

    By: Tomomichi Amano, Elie Ofek, Mengjie Cheng and Amy Klopfenstein
More from the Authors
  • Thinking Outside the Wine Box (C): Mekanism and the Franz for Life Campaign By: Tomomichi Amano, Elie Ofek, Mengjie Cheng and Amy Klopfenstein
  • Thinking Outside the Wine Box (B): Mekanism and the Franz for Life Campaign By: Tomomichi Amano, Elie Ofek, Mengjie Cheng and Amy Klopfenstein
  • Thinking Outside the Wine Box (A): Mekanism and the Franz for Life Campaign By: Tomomichi Amano, Elie Ofek, Mengjie Cheng and Amy Klopfenstein
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College